Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Francesca Schieppati, Anna Falanga

Journal: Hematology. American Society of Hematology. Education Program 2022;2021(1):448-452

PMID: 34889434

Free Full Text on PubMed Central View on PubMed

Abstract

DOI: 10.1182/hematology.2021000318

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/bloodthinners.html

Subscription / membership required

Full Text Sources:

https://ashpublications.org/hematology/article-loo...

MeSH Terms: Anticoagulants, Factor Xa Inhibitors, Humans, Male, Middle Aged, Myeloproliferative Disorders, Venous Thromboembolism, Vitamin K

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.